Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Visco VisionTPE:6782 -3.61%99 Earnings per Share (Diluted) is NT$16.40 as of Jun. 2026. GuruFocus rates TPE:6782 with a GF Score™ of 99/100 and a GF Value™ of NT$255.44 (Fairly Valued). The stock has 4 warning signs investors should review. Among 662 Medical Devices & Instruments companies, Visco Vision ranks worse than 50.3% on this metric.
Visco Vision's EPS (Basic) for the
three
months ended in Jun. 2026 was NT$4.64.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$16.49.
Visco Vision's EPS without NRI for the
three
months ended in Jun. 2026 was NT$4.62.
Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was NT$16.47.
During the past 12 months, Visco Vision's average EPS without NRIGrowth Rate was 48.40% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 7.80% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 28.40% per year.
During the past 9 years, Visco Vision's highest 3-Year average EPS without NRI Growth Rate was 30.10% per year. The lowest was 7.00% per year. And the median was 25.70% per year.
Visco Vision (TPE:6782) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Visco Vision Earnings per Share (Diluted) Related Terms
Visco Vision Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Visco Vision's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6782 vs ISRG, BDX, RMD: Earnings per Share (Diluted) Comparison
For the Medical Instruments & Supplies subindustry, Visco Vision's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Visco Vision PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Visco Vision's PE Ratio distribution charts can be found below:
* The bar in red indicates where Visco Vision's PE Ratio falls into.
Visco Vision Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Visco Vision's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$16.40
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of NT$16.40 mean?
Visco Vision (TPE:6782) has a Earnings per Share (Diluted) of NT$16.40 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Visco Vision and its competitors. According to the industry distribution chart, Visco Vision ranks #333 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 50.3%.
Is Visco Vision's Earnings per Share (Diluted) too high?
Visco Vision's current Earnings per Share (Diluted) is NT$16.40. Based on the distribution chart, Visco Vision ranks #333 out of 662 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Visco Vision has a GF Score™ of 99/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Visco Vision's Earnings per Share (Diluted) compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Visco Vision ranks #333 out of 662 companies for Earnings per Share (Diluted). This places Visco Vision in the lower half of its industry. The industry median Earnings per Share (Diluted) is 8.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Devices & Instruments company?
The median Earnings per Share (Diluted) among Medical Devices & Instruments companies is 8.05, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Visco Vision and its competitors. For the Medical Devices & Instruments industry, the median Earnings per Share (Diluted) is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Visco Vision's current Earnings per Share (Diluted) is NT$16.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Visco Vision stock overvalued right now?
Based on GuruFocus' analysis, Visco Vision (TPE:6782) is currently considered Fairly Valued. The stock's GF Value™ is NT$255.44, compared to a current price of NT$240.00 — trading 6% below its estimated fair value. The current Earnings per Share (Diluted) is NT$16.40. Visco Vision's overall GF Score™ is 99/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Visco Vision (TPE:6782), the current Earnings per Share (Diluted) is NT$16.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Visco Vision (TPE:6782) Overvalued in 2026?
Based on GuruFocus' analysis, Visco Vision stock appears to be undervalued.
The current stock price of NT$240.00 is trading 6% below its estimated GF Value™ of NT$255.44.
GuruFocus considers Visco Vision to be Fairly Valued.
Key valuation signals for TPE:6782:
Earnings per Share (Diluted): NT$16.40
GF Value™: NT$255.44 vs. price of NT$240.00 (6% below fair value)
No single metric tells the full story. See the TPE:6782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Visco Vision Inc is a manufacturer and seller of disposable contact lenses. The company manufactures Spherical Lenses, Multifocal lenses, Toric lenses, and Cosmetic lenses. Geographically, the company earns maximum revenue from Asia, followed by Europe, Taiwan, and the Americas.
99GF Score
Get the complete analysis for TPE:6782
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6782 has been successfully added to your 
